← Insider buys
BMRN

BioMarin Pharmaceutical Inc. · Healthcare

CEO Jean Jacques Bienaime sold $367K of BioMarin Pharmaceutical Inc.

Sold$367,120
$91.78Price
4,000Shares
−1%Stake

What BMRN did after the filing

Prices for BMRN after this filing aren't in yet.

Traded Wed, Feb 27. Filed Thu, Feb 28, 8:24 PM ET, after the close. Not investment advice.